超声造影诊断微小原发性肝癌患者临床价值研究

doi:10.3969/j.issn.1672-5069.2018.05.022

Abstract

Abstract: Objective To investigate the clinical application of ultrasonography in the early diagnosis of patients with small primary liver cancer （PLC）. Methods 156 individuals with high risk of PLC were monitored by ultrasonography in the Department of Oncology between January 2016 and December 2016 in this study. Computed tomography（CT）,and magnetic resonance imaging（MRI） were performed within 15 days after contrast-enhanced sonography. The pathologic diagnosis was made by surgical histopathological examination or fine needle biopsy. Results Out of the 156 persons with high risk of PLC,29 malignant and 14 suspected malignant foci were found by routine sonography,while 32 malignant and 9 suspected malignant foci were detected by contrast-enhanced sonography;32 hepatocellular caicinoma （HCC） and 9 suspected malignant foci were confirmed by pathology;out of the 32 patients with HCC,17 were men,and 15 women with a average age of 48.56±2.05 （20~69） yr,the diameter of foci was 0.8~2（1.62±0.12） cm,and the foci was arterial enhancement and hypoechogenicity in portal and delayed phase in 13,and keeping enhancement in three phase in 19. Conclusions Regular monitoring of ultrasonography is necessary in individuals with high risk of PLC for early diagnosis of malignant foci.

Key words: Hepatoma, Ultrasonography, Diagnosis, High risk

Guo Zhengning.. Contrast-enhanced ultrasound monitoring in early diagnosis of patients with small primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 741-744.

References

[1] 贾春梅,李廷廷,康春松,等.肝硬化结节与小肝癌实时超声造影定量比较研究.中华超声影像学杂志,2013,22(2):123-126.
[2] Wang Z,Lin M,Lesage D,et al.Three-dimensional evaluation of lipiodol retention in PLC after chemoembolization:A quantitative comparison between CBCT and MDCT. Acad Radiol,2014,21(3):393-399.
[3] Quaia E,Degobbis F,Tona G,et al.Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue. Radiol Med,2014,10(8):155-165.
[4] 中华医学会传染病和寄生虫病学分会,肝病分会. 病毒性肝炎防治方案. 中华肝脏病杂志,2000,8(6):324-329.
[5] Kastelan S,Ljubicic N.The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterology,2004,51(59):1408-1412.
[6] Yeun C,Soon B.Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol,2003,18(4):424-429.
[7] Novell A,Escoffre JM,Bouakaz A,et al.Second harmonic and subharmonic for non-linear wideband contrast imaging using a capacitive micromachined ultrasonic transducer array. Ultrasound Med Biol,2013,39(8):1500-1512.
[8] D'Onofrio M,Crosara S,De Robertis H,et al. Contrast-enhanced ultrasound of focal liver lesions. AJR,2015,205(1):W56-66.
[9] Wang YH, Li PC.SNR-dependent coherence-based adaptive imaging for high-frame-rate ultrasonic and photoacoustic imaging. IEEE Trans Ultrason Ferroelectr Freq Control,2014,61(8):1419-1432.
[10] 严昆,陈敏华,张秀梅,等. 超声造影指导射频消融治疗小肝癌的应用价值. 中华超声影像学杂志,2011,20(1):18-21.
[11] Carr BI,D'Alessandro R,Refolo MG,et al. Effects of low concentrations of regorafenib and sorafenib on human PLC cell AFP,migration,invasion,and growth in vitro. J Cell Physiol,2013,228(6):1344-1350.
[12] 张宁宁,程晓静,刘建勇,等. 大功率微波消融治疗肝癌临床疗效及其复发危险因素分析. 实用肝脏病杂志,2015,18(3):249-253.
[13] Abbattista T,Ridolfi F.Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography. La Radiologia Med,2008,113(6):860-874.
[14] Di Vece F,Tombesi P,Ermili F,et al.Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using adevice to decrease back-heating effects:a prospective pilot study. Cardiovasc Int Radiol,2014,37(3):723-729.
[15] Sciarra A,Di Tommaso L,Nakano M,et al.Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications. J Hepatol,2016,64(1):87-93.
[16] Choi BI,Lee JM,Kim TK,et al.Diagnosing borderline hepaticnodules in hepatocarcinogenesis:Imaging performance. AJR,2015,205(1):10-21.
[17] Kim TK,Jang HJ.Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol,2014,20(13):3590-3596.
[18] Yan Z,Duan Y.Noninvasive quantitative testing of liver function using ultrasonography inpatients with cirrhosis. Hepatogastroenterology,2006,53(67):15-20.
[19] Borchert D,Schuler A.Comparison of panorama ultrasonography,conventional B-mode ultrasonography,and computed tomography for measuring liver size. Ultraschall Der Med,2009,31(1):31-36. [20] 李真真,王绮,张延瑞,等. 复发性肝细胞性小肝癌超声造影强化模式量化分析. 实用医学杂志,2016,32(5):774-777.
[21] 苏旭,刘育健,李滨,等. 经皮微波消融术治疗小肝癌31例临床分析. 中国卫生标准管理,2016,7(15):86-88.
[22] 谭军. 肝硬化背景下超声造影诊断小肝癌的应用研究.中国医药指南,2011,9(32):83-84.
[23] 王洁,云文耀,袁素馨,等. 超声造影定量分析鉴别小肝癌与癌前病变的初步研究. 影像诊断与介入放射学,2013,22(2):133-135.
[24] 肖颖,徐栋超声造影用于肝硬化合并小肝癌早期诊断意义评价.现代实用医学,2016,28(4):485-486.
[25] 侯丽坤,李海呜. 肝硬化超声造影对常规超声不显像小肝癌的检出价值. 山西医药杂志,2012,41(2):143-145.
[26] 何志容,殷军,宋鑫,等. 肝脏局灶性小病变的超声造影研究. 临床超声医学杂志,2014,16(7):484-486.
[27] 贾春梅,李廷廷,康春松,等. 肝硬化结节与小肝癌实时超声造影定量比较研究. 中华超声影像学杂志,2013,22(2):123-126.

Contrast-enhanced ultrasound monitoring in early diagnosis of patients with small primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Ye Xianjun, He Nian’an, Sui Xiufang, et al.. Contrast-enhanced ultrasonographic features of hepatic epitheloid hemangioendothelioma [J]. Journal of Practical Hepatology, 2019, 22(6): 904-907.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[11]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[12]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[13]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[14]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[15]	Yan Ruibin, Ma Shumei, Zhuo Ma, et al. Significance of portal vain parameters by ultrasonography and serum MMP-2 and TIMP-2 detection in evaluation of liver fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 506-509.